GLYPHIC BIOTECHNOLOGIES
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
GLYPHIC BIOTECHNOLOGIES
Industry:
Biotechnology Life Science
Founded:
2021-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.glyphic.bio
Total Employee:
11+
Status:
Active
Total Funding:
9.37 M USD
Technology used in webpage:
Google Apps For Business Microsoft Azure DNS Accelerated Mobile Pages
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Catena Biosciences
Biotech company focused on protein conjugation.
Mana Therapeutics
Next-Generation Immunotherapies
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Quantum SI
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Joshua Yang Co-Founder and CEO @ Glyphic Biotechnologies
Co-Founder and CEO
Daniel Estandian Co-Founder and CTO @ Glyphic Biotechnologies
Co-Founder and CTO
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Glyphic Biotechnologies
New York State’s Empire State Development Fund
New York State’s Empire State Development Fund investment in Grant - Glyphic Biotechnologies
Qiagen
Qiagen investment in Grant - Glyphic Biotechnologies
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Grant - Glyphic Biotechnologies
Artis Ventures (AV)
Artis Ventures (AV) investment in Seed Round - Glyphic Biotechnologies
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Seed Round - Glyphic Biotechnologies
Axial VC
Axial VC investment in Seed Round - Glyphic Biotechnologies
Wing Venture Capital
Wing Venture Capital investment in Seed Round - Glyphic Biotechnologies
Civilization Ventures
Civilization Ventures investment in Seed Round - Glyphic Biotechnologies
OMX Ventures
OMX Ventures investment in Seed Round - Glyphic Biotechnologies
Official Site Inspections
http://www.glyphic.bio Semrush global rank: 5.54 M Semrush visits lastest month: 1.53 K
- Host name: 192.0.78.155
- IP address: 192.0.78.155
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
Cannot get whois informations of this domain!!!
More informations about "Glyphic Biotechnologies"
Glyphic Biotechnologies – Next Generation Protein …
Enter your email address to subscribe to Glyphic Biotechnologies and receive notifications of our updates by email. Email Address Subscribe Revolutionizing proteomics, one amino acid at a time. 3100 San Pablo Avenue #201 Berkeley, …See details»
Glyphic Biotechnologies - Crunchbase Company Profile …
Organization. Glyphic Biotechnologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
glyphicbio – Glyphic Biotechnologies
Jul 8, 2021 Glyphic Biotechnologies is 1 of 25 winners in the Falling Walls Venture 2021 competition and will be competing in Berlin for Science Startup Breakthrough of the Year. ... today announced the ten companies selected to …See details»
Glyphic Biotechnologies | Seed - National Institutes of Health
Glyphic Biotechnologies is developing a single-molecule, massively parallel protein sequencing platform that does not rely on the existing, decades-old technologies of ELISA and mass …See details»
Glyphic Biotechnologies - Harpoon Ventures
Glyphic Bio is transforming the field of proteomics by making it possible to sequence all 20 amino acids with single-molecule precision. While DNA sequencing revolutionized biomedical …See details»
Glyphic Biotechnologies Launches Berkeley …
Glyphic Biotechnologies, whose Co-founder Josh Yang is pictured, is moving forward with plans to expand into 31,000 square feet at Foundry31. ... Nosis Bio, a startup developing …See details»
How Does Glyphic Biotechnologies Work? – CANVAS, SWOT, …
Dec 19, 2024 Website: https://www.glyphic.bio; Focus: Protein sequencing platform development; By providing researchers with advanced tools and technologies, Glyphic …See details»
Glyphic Biotechnologies raises $6M to …
Jul 26, 2021 Glyphic Biotechnologies accelerates the critical but slow sequencing step, potentially cutting drug development times down by a huge amount, and the startup just raised a $6 …See details»
Glyphic Biotechnologies Recognized as 1 of 10 Best-in …
Jul 29, 2021 BioTools Innovator, a new program focused on accelerating life science tools and diagnostics, today announced the ten companies selected to participate in the organization’s inaugural three-month virtual mentorship …See details»
Glyphic Biotechnologies - VentureRadar
" Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolutions, advancing beyond the decades old technologies …See details»
Glyphic Biotechnologies – Startups.Bio
Apr 27, 2022 Glyphic Biotechnologies is an MIT spin-out aiming to accelerate the critical but slow step of sequencing new proteins, potentially cutting drug development times down by several orders of magnitude.. No technology …See details»
Glyphic Biotechnologies - Craft
Glyphic Biotechnologies has 5 employees at their 1 location and $6.03 m in total funding,. See insights on Glyphic Biotechnologies including office locations, competitors, revenue, financials, …See details»
Founder Spotlight #40: Josh Yang @ Glyphic …
May 10, 2022 Glyphic Bio is a proteomics platform company enabling the development of novel therapeutics, diagnostics, and ultimately, a deeper understanding of human biology. Although decoding the human ...See details»
Glyphic Biotechnologies – Funding, Valuation, Investors, News
Jun 14, 2023 We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins …See details»
The dawn of a revolutionary platform | Sensu.health
The platform that Glyphic is constructing is in alignment with a broader industry shift, as proteomics continues to gain prominence alongside genomics and transcriptomics. This is an …See details»
Glyphic Biotechnologies Revenue, Growth & Competitor Profile
Mar 10, 2025 Glyphic Biotechnologies's annual revenues are $1 - $10 million (see exact revenue data) What industry is the company in? Glyphic Biotechnologies is classified as operating in …See details»
LongeVC Backs Glyphic Bio to Back Next-Gen Protein Sequencing
Nov 21, 2024 Glyphic Bio’s technology not only has strong potential within proteomics—a market poised for substantial growth—but also holds applications across other rapidly evolving …See details»
Glyphic Biotechnologies - Contacts, Employees, Board Members, …
Organization. Glyphic Biotechnologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contacts 12. About. Glyphic Biotechnologies has 2 current …See details»
Tenant Spotlight: Decoding the Human Proteome With Glyphic ...
After Daniel met CEO Josh Yang online via Nucleate Bio, the duo decided to create their own answer: Glyphic Bio. “I’ve been working on it for six years. It’s an obvious problem that I find …See details»
Glyphic Biotechnologies is developing a single-molecule …
Sep 7, 2021 Glyphic Biotechnologies is developing a single-molecule-resolution protein sequencing platform By Samantha Black, PhD, ScienceBoard editor in chief. September 7, …See details»